Go Pro
LON:CNSL

Cambridge Nutritional Sciences Interim Earnings Report

GBX 1.58 +0.10 (+6.78%)
As of 09/21/2026 12:00 PM Eastern

Cambridge Nutritional Sciences EPS Results

Actual EPS
-GBX 0.20
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cambridge Nutritional Sciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cambridge Nutritional Sciences Announcement Details

Quarter
Interim
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Cambridge Nutritional Sciences Earnings Headlines

A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
See More Cambridge Nutritional Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cambridge Nutritional Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cambridge Nutritional Sciences and other key companies, straight to your email.

About Cambridge Nutritional Sciences

Cambridge Nutritional Sciences (LON:CNSL) (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

View Cambridge Nutritional Sciences Profile